Pre-operative embolization of hypervascular spinal metastasis using percutaneous direct intra-tumoural injection with Onyx under local anesthesia

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Intra-operative blood loss remains a major cause of perioperative morbidity for patients with hypervascular spinal metastasis undergoing surgery. Pre-operative embolization is used to reduce intraoperative blood loss and operative time. This is commonly performed under general anesthesia via a trans-arterial approach, which carries a risk of spinal stroke. We propose an alternative technique for embolization of hypervascular metastases using the Onyx embolic agent via a percutaneous direct intra-tumoural injection under local anesthesia and sedation to reduce embolization risks and procedure time, as well as operative blood loss and operative time. A 74-year-old man presented with thoracic myelopathy with back and radicular pain on background of metastatic renal cell carcinoma. Magnetic resonance imaging (MRI) revealed a 3. cm mass centered on the right lamina of T10 with extension into the spinal canal. The patient underwent a percutaneous imaging-guided direct intra-tumoural contrast parenchymogram, and Onyx embolization via a single needle. Initial needle placement and tumour assessment was completed in 30. min; embolization time was 15. min. Complete devascularization was achieved with no complications. Surgical resection was performed with lower than expected operative blood loss (150. ml) and operative time (90. min). His pre-operative symptoms improved, and he was discharged home the following day. At 6-month follow-up there was no recurrence of his symptoms. Further evaluation of direct percutaneous intra-tumoural Onyx embolization for hypervascular spinal tumours is warranted.

Original languageEnglish
Pages (from-to)306-309
Number of pages4
JournalJournal of Clinical Neuroscience
Volume44
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Myelopathy
  • Onyx
  • Operative blood loss
  • Preoperative embolization
  • Renal cell carcinoma
  • Spinal metastasis

Cite this

@article{a66d71fcc4aa4e179c3a7a4aed8f51bf,
title = "Pre-operative embolization of hypervascular spinal metastasis using percutaneous direct intra-tumoural injection with Onyx under local anesthesia",
abstract = "Intra-operative blood loss remains a major cause of perioperative morbidity for patients with hypervascular spinal metastasis undergoing surgery. Pre-operative embolization is used to reduce intraoperative blood loss and operative time. This is commonly performed under general anesthesia via a trans-arterial approach, which carries a risk of spinal stroke. We propose an alternative technique for embolization of hypervascular metastases using the Onyx embolic agent via a percutaneous direct intra-tumoural injection under local anesthesia and sedation to reduce embolization risks and procedure time, as well as operative blood loss and operative time. A 74-year-old man presented with thoracic myelopathy with back and radicular pain on background of metastatic renal cell carcinoma. Magnetic resonance imaging (MRI) revealed a 3. cm mass centered on the right lamina of T10 with extension into the spinal canal. The patient underwent a percutaneous imaging-guided direct intra-tumoural contrast parenchymogram, and Onyx embolization via a single needle. Initial needle placement and tumour assessment was completed in 30. min; embolization time was 15. min. Complete devascularization was achieved with no complications. Surgical resection was performed with lower than expected operative blood loss (150. ml) and operative time (90. min). His pre-operative symptoms improved, and he was discharged home the following day. At 6-month follow-up there was no recurrence of his symptoms. Further evaluation of direct percutaneous intra-tumoural Onyx embolization for hypervascular spinal tumours is warranted.",
keywords = "Myelopathy, Onyx, Operative blood loss, Preoperative embolization, Renal cell carcinoma, Spinal metastasis",
author = "Lim, {Kai Zheong} and Tony Goldschlager and Chandra, {Ronil V.}",
year = "2017",
month = "10",
doi = "10.1016/j.jocn.2017.07.003",
language = "English",
volume = "44",
pages = "306--309",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Elsevier - Mosby",

}

TY - JOUR

T1 - Pre-operative embolization of hypervascular spinal metastasis using percutaneous direct intra-tumoural injection with Onyx under local anesthesia

AU - Lim, Kai Zheong

AU - Goldschlager, Tony

AU - Chandra, Ronil V.

PY - 2017/10

Y1 - 2017/10

N2 - Intra-operative blood loss remains a major cause of perioperative morbidity for patients with hypervascular spinal metastasis undergoing surgery. Pre-operative embolization is used to reduce intraoperative blood loss and operative time. This is commonly performed under general anesthesia via a trans-arterial approach, which carries a risk of spinal stroke. We propose an alternative technique for embolization of hypervascular metastases using the Onyx embolic agent via a percutaneous direct intra-tumoural injection under local anesthesia and sedation to reduce embolization risks and procedure time, as well as operative blood loss and operative time. A 74-year-old man presented with thoracic myelopathy with back and radicular pain on background of metastatic renal cell carcinoma. Magnetic resonance imaging (MRI) revealed a 3. cm mass centered on the right lamina of T10 with extension into the spinal canal. The patient underwent a percutaneous imaging-guided direct intra-tumoural contrast parenchymogram, and Onyx embolization via a single needle. Initial needle placement and tumour assessment was completed in 30. min; embolization time was 15. min. Complete devascularization was achieved with no complications. Surgical resection was performed with lower than expected operative blood loss (150. ml) and operative time (90. min). His pre-operative symptoms improved, and he was discharged home the following day. At 6-month follow-up there was no recurrence of his symptoms. Further evaluation of direct percutaneous intra-tumoural Onyx embolization for hypervascular spinal tumours is warranted.

AB - Intra-operative blood loss remains a major cause of perioperative morbidity for patients with hypervascular spinal metastasis undergoing surgery. Pre-operative embolization is used to reduce intraoperative blood loss and operative time. This is commonly performed under general anesthesia via a trans-arterial approach, which carries a risk of spinal stroke. We propose an alternative technique for embolization of hypervascular metastases using the Onyx embolic agent via a percutaneous direct intra-tumoural injection under local anesthesia and sedation to reduce embolization risks and procedure time, as well as operative blood loss and operative time. A 74-year-old man presented with thoracic myelopathy with back and radicular pain on background of metastatic renal cell carcinoma. Magnetic resonance imaging (MRI) revealed a 3. cm mass centered on the right lamina of T10 with extension into the spinal canal. The patient underwent a percutaneous imaging-guided direct intra-tumoural contrast parenchymogram, and Onyx embolization via a single needle. Initial needle placement and tumour assessment was completed in 30. min; embolization time was 15. min. Complete devascularization was achieved with no complications. Surgical resection was performed with lower than expected operative blood loss (150. ml) and operative time (90. min). His pre-operative symptoms improved, and he was discharged home the following day. At 6-month follow-up there was no recurrence of his symptoms. Further evaluation of direct percutaneous intra-tumoural Onyx embolization for hypervascular spinal tumours is warranted.

KW - Myelopathy

KW - Onyx

KW - Operative blood loss

KW - Preoperative embolization

KW - Renal cell carcinoma

KW - Spinal metastasis

UR - http://www.scopus.com/inward/record.url?scp=85026514175&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2017.07.003

DO - 10.1016/j.jocn.2017.07.003

M3 - Article

VL - 44

SP - 306

EP - 309

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -